Skip to Main Content

Paper Details

A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome.
Front Immunol
3
2023
C-peptide, DXCR, GLO1, IL-6, Melanoma, OSMR, Patients, T1DM, Type 1 diabetes mellitus, anti-PD1, blood specimens, diabetic ketoacidosis, glucose, immune, insulin, melanoma, patients, solid tumors, type 1 diabetes mellitus
Author NameAffiliation
Jennifer A DohertyHuntsman Cancer Institute, University of Utah Health
Jennifer A DohertyHuntsman Cancer Institute, University of Utah Health
  • 1 - 2

Datasets

Release 1.2